PBPK modeling

1:05:07

First in Human (FIH) PBPK predictions

0:22:23

Application of PBPK Modelling to Drug Development Decisions | Joga Gobburu, PhD, MBA

0:50:49

PBPK Modeling and Simulation for Regulatory Decision Making: Impact on US Prescribing Information

0:36:08

PBPK Modeling of Antibody-Drug Conjugates – Concept and Application

0:36:24

Physiologically-based Pharmacokinetics Modeling: An Approach for Designing Better Clinical Trials

1:23:25

Application of PBPK Modeling in Pediatric Drug Development (GastroPlus®)

1:01:04

PBPK modeling to assess the impact of diseases on oral drug absorption case study in HIV infected

0:52:12

Webinar 27 - Understanding PBPK Modeling and IVIVE: Fundamentals and Applications

0:58:59

PBPK Modeling of Pulmonary Drug Absorption: Challenges & Perspective

0:46:59

Physiologically-Based (PBPK) & Population Pharmacokinetic Modeling in Molecular Radiotherapy

0:16:24

PBPK modeling and simulation used in assessing BE for generic ophthalmic products (19of39)

1:09:09

Incorporating transporter kinetics into PBPK models

0:57:39

Better Together: AI/ML, PBPK and QSP/QST Modeling in Drug Discovery & Development

0:00:32

Discover our PBBM/PBPK Modeling Software & Experts

0:34:15

Using PBPK Modeling for Risk Assessment in Drug Product Development

1:02:16

Leveraging Dermal PBPK Modeling and Simulation Approaches

0:13:20

Developing Compound Files for PBPK Modeling in the Simcyp Simulator

0:58:30

Predicting Drug Exposure During Pregnancy Using PBPK Models

1:20:40

Mechanistic In Vitro Dissolution PBPK Models to Drive Drug Development

1:01:14

PBPK Modeling & Simulation to Support asciminib NDA Submission and Inform Drug Product Label

0:39:17

An Introduction to PBPK, Simcyp Discovery, and the Simcyp Product Suite

0:56:08

PBPK modeling approach for evaluating drug product performance in infants based on adults

0:24:20

Complex Delivery Routes and Generics: The Next Frontier for PBBM/PBPK Modeling

0:15:48

Using PBPK Absorption Modeling to Support Biopharmaceutics Classification System Class 3 Drug Waiver